246 related articles for article (PubMed ID: 17636123)
1. Structural basis of antigenic escape of a malaria vaccine candidate.
Dutta S; Lee SY; Batchelor AH; Lanar DE
Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12488-93. PubMed ID: 17636123
[TBL] [Abstract][Full Text] [Related]
2. Overcoming antigenic diversity by enhancing the immunogenicity of conserved epitopes on the malaria vaccine candidate apical membrane antigen-1.
Dutta S; Dlugosz LS; Drew DR; Ge X; Ababacar D; Rovira YI; Moch JK; Shi M; Long CA; Foley M; Beeson JG; Anders RF; Miura K; Haynes JD; Batchelor AH
PLoS Pathog; 2013; 9(12):e1003840. PubMed ID: 24385910
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
Lalitha PV; Biswas S; Pillai CR; Saxena RK
Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
[TBL] [Abstract][Full Text] [Related]
4. Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate.
Ntege EH; Arisue N; Ito D; Hasegawa T; Palacpac NMQ; Egwang TG; Horii T; Takashima E; Tsuboi T
Vaccine; 2016 Nov; 34(46):5612-5622. PubMed ID: 27692771
[TBL] [Abstract][Full Text] [Related]
5. Alanine mutagenesis of the primary antigenic escape residue cluster, c1, of apical membrane antigen 1.
Dutta S; Dlugosz LS; Clayton JW; Pool CD; Haynes JD; Gasser RA; Batchelor AH
Infect Immun; 2010 Feb; 78(2):661-71. PubMed ID: 19948834
[TBL] [Abstract][Full Text] [Related]
6. Allelic polymorphisms in apical membrane antigen-1 are responsible for evasion of antibody-mediated inhibition in Plasmodium falciparum.
Healer J; Murphy V; Hodder AN; Masciantonio R; Gemmill AW; Anders RF; Cowman AF; Batchelor A
Mol Microbiol; 2004 Apr; 52(1):159-68. PubMed ID: 15049818
[TBL] [Abstract][Full Text] [Related]
7. Genetic diversity and natural selection at the domain I of apical membrane antigen-1 (AMA-1) of Plasmodium falciparum in isolates from Iran.
Mardani A; Keshavarz H; Heidari A; Hajjaran H; Raeisi A; Khorramizadeh MR
Exp Parasitol; 2012 Apr; 130(4):456-62. PubMed ID: 22306282
[TBL] [Abstract][Full Text] [Related]
8. Structure and Characterisation of a Key Epitope in the Conserved C-Terminal Domain of the Malaria Vaccine Candidate MSP2.
Seow J; Morales RA; MacRaild CA; Krishnarjuna B; McGowan S; Dingjan T; Jaipuria G; Rouet R; Wilde KL; Atreya HS; Richards JS; Anders RF; Christ D; Drinkwater N; Norton RS
J Mol Biol; 2017 Mar; 429(6):836-846. PubMed ID: 28189425
[TBL] [Abstract][Full Text] [Related]
9. Defining the antigenic diversity of Plasmodium falciparum apical membrane antigen 1 and the requirements for a multi-allele vaccine against malaria.
Drew DR; Hodder AN; Wilson DW; Foley M; Mueller I; Siba PM; Dent AE; Cowman AF; Beeson JG
PLoS One; 2012; 7(12):e51023. PubMed ID: 23227229
[TBL] [Abstract][Full Text] [Related]
10. Stability and potency of the Plasmodium falciparum MSP1-19/AMA-1(III) chimeric vaccine candidate with Montanide ISA720 adjuvant.
Xue X; Ding F; Zhang Q; Pan X; Qu L; Pan W
Vaccine; 2010 Apr; 28(18):3152-8. PubMed ID: 20197139
[TBL] [Abstract][Full Text] [Related]
11. Invasion-inhibitory antibodies inhibit proteolytic processing of apical membrane antigen 1 of Plasmodium falciparum merozoites.
Dutta S; Haynes JD; Moch JK; Barbosa A; Lanar DE
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12295-300. PubMed ID: 14526103
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implications.
Ouattara A; Takala-Harrison S; Thera MA; Coulibaly D; Niangaly A; Saye R; Tolo Y; Dutta S; Heppner DG; Soisson L; Diggs CL; Vekemans J; Cohen J; Blackwelder WC; Dube T; Laurens MB; Doumbo OK; Plowe CV
J Infect Dis; 2013 Feb; 207(3):511-9. PubMed ID: 23204168
[TBL] [Abstract][Full Text] [Related]
13. Structure of domain III of the blood-stage malaria vaccine candidate, Plasmodium falciparum apical membrane antigen 1 (AMA1).
Nair M; Hinds MG; Coley AM; Hodder AN; Foley M; Anders RF; Norton RS
J Mol Biol; 2002 Sep; 322(4):741-53. PubMed ID: 12270711
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of the leading malaria vaccine candidate AMA-1 reveals an essential role for the cytoplasmic domain in the invasion process.
Treeck M; Zacherl S; Herrmann S; Cabrera A; Kono M; Struck NS; Engelberg K; Haase S; Frischknecht F; Miura K; Spielmann T; Gilberger TW
PLoS Pathog; 2009 Mar; 5(3):e1000322. PubMed ID: 19283086
[TBL] [Abstract][Full Text] [Related]
15. A diversity-covering approach to immunization with Plasmodium falciparum apical membrane antigen 1 induces broader allelic recognition and growth inhibition responses in rabbits.
Remarque EJ; Faber BW; Kocken CH; Thomas AW
Infect Immun; 2008 Jun; 76(6):2660-70. PubMed ID: 18378635
[TBL] [Abstract][Full Text] [Related]
16. Production of the subdomains of the Plasmodium falciparum apical membrane antigen 1 ectodomain and analysis of the immune response.
Lalitha PV; Ware LA; Barbosa A; Dutta S; Moch JK; Haynes JD; Fileta BB; White CE; Lanar DE
Infect Immun; 2004 Aug; 72(8):4464-70. PubMed ID: 15271904
[TBL] [Abstract][Full Text] [Related]
17. Allele specificity of naturally acquired antibody responses against Plasmodium falciparum apical membrane antigen 1.
Cortés A; Mellombo M; Masciantonio R; Murphy VJ; Reeder JC; Anders RF
Infect Immun; 2005 Jan; 73(1):422-30. PubMed ID: 15618180
[TBL] [Abstract][Full Text] [Related]
18. Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine.
Ouattara A; Mu J; Takala-Harrison S; Saye R; Sagara I; Dicko A; Niangaly A; Duan J; Ellis RD; Miller LH; Su XZ; Plowe CV; Doumbo OK
Malar J; 2010 Jun; 9():175. PubMed ID: 20565971
[TBL] [Abstract][Full Text] [Related]
19. Fusion of two malaria vaccine candidate antigens enhances product yield, immunogenicity, and antibody-mediated inhibition of parasite growth in vitro.
Pan W; Huang D; Zhang Q; Qu L; Zhang D; Zhang X; Xue X; Qian F
J Immunol; 2004 May; 172(10):6167-74. PubMed ID: 15128804
[TBL] [Abstract][Full Text] [Related]
20. High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion.
Kocken CH; Withers-Martinez C; Dubbeld MA; van der Wel A; Hackett F; Valderrama A; Blackman MJ; Thomas AW
Infect Immun; 2002 Aug; 70(8):4471-6. PubMed ID: 12117958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
